Glipizide
- Product NDC
- 52817-385
- 11-digit product format
- 528170385
- Labeler code
- 52817
- Product ID
- 52817-385_076b74ec-ead5-781c-e063-6394a90ab362
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- TruPharma LLC
- Application
- ANDA214874
- Marketing category
- ANDA
- Marketing start
- 2023-10-03
- Substance
- GLIPIZIDE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 379804 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52817-385-10 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 52817-385-50 | Glipizide | 500 in 1 BOTTLE | TABLET | 500 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52817-385 | GLIPIZIDE TABLET [TRUPHARMA LLC] | 1 | Current NDC, 2 package rows | 20231011_95ea4c96-84b9-4515-9494-a93d26820f70.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 52817-385-10 | 52817038510 | 100 TABLET in 1 BOTTLE (52817-385-10) | 100 tablet | 2023-10-03 | No | No | Historical |
| 52817-385-50 | 52817038550 | 500 TABLET in 1 BOTTLE (52817-385-50) | 500 tablet | 2023-10-03 | No | No | Historical |